-
Je něco špatně v tomto záznamu ?
Clostridium difficile infection in hospitalized patients at a Czech tertiary center: analysis of epidemiology, clinical features, and risk factors of fulminant course
K. Balihar, F. Kozak, J. Kozeluhova, V. Hejda, L. Fremundova, M. Krcma, L. Geigerova, T. Bergerova, M. Matejovic,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- antibakteriální látky terapeutické užití MeSH
- časná diagnóza MeSH
- centra terciární péče MeSH
- délka pobytu statistika a číselné údaje MeSH
- hospitalizace MeSH
- incidence MeSH
- infekce spojené se zdravotní péčí epidemiologie přenos MeSH
- lidé středního věku MeSH
- lidé MeSH
- mortalita v nemocnicích MeSH
- prognóza MeSH
- pseudomembranózní enterokolitida diagnóza farmakoterapie epidemiologie přenos MeSH
- retrospektivní studie MeSH
- rizikové faktory MeSH
- senioři MeSH
- spotřeba léčiv statistika a číselné údaje MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
OBJECTIVE: Clostridium difficile infection (CDI) has been increasing in incidence, with significant morbidity and mortality, and is subject to geographical and institutional variability. We aimed to characterize epidemiology and clinical manifestations of CDI in a Czech tertiary care center and to identify risk factors of fulminant course. METHODS: All adult patients hospitalized with primary CDI in a 3-year period were retrospectively identified. Epidemiological and clinically descriptive data were extracted from medical records. Multivariate analysis was used to identify the risk factors of fulminant course. The relationship between incidence of CDI and antibiotic consumption was evaluated. RESULTS: Overall, 183 CDI patients, median age 67 years, were enrolled. Hospital-acquired CDI was present in 85% of cases. The incidence of CDI was 1/10,000 patient-days. Hospital-acquired CDI hospital mortality was 22.4%. Severe CDI (SCDI) was identified in 15.8% of patients, with 62% mortality. SCDI patients had longer onset of symptoms to diagnosis interval compared with mild CDI (P=0.05). Multivariate analysis showed that SCDI patients were older (P=0.018), and more frequently had abnormal abdominal physical findings (P=0.001), higher inflammatory markers (P<0.001), higher creatinine (P=0.002), and lower albumin (P<0.001) than patients with mild CDI. Analysis of antibiotic consumption at departments with the highest incidence of CDI showed a trend toward higher incidence of CDI associated with penicillin use (P=0.08) and a negative correlation of CDI incidence with nitroimidazoles consumption (P=0.03). CONCLUSION: CDI is less frequent in the conditions studied compared with literary data; however, the fulminant form has a very high mortality. Delayed recognition and treatment is a crucial determinant of the severity of CDI. The association between CDI and antibiotic consumption is less clear.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15023324
- 003
- CZ-PrNML
- 005
- 20150730105340.0
- 007
- ta
- 008
- 150709s2014 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/MEG.0000000000000139 $2 doi
- 035 __
- $a (PubMed)24942955
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Balihar, Karel $u aDepartment of Internal Medicine, Division of Gastroenterology and Hepatology bDepartment of Microbiology, Charles University Medical School and Teaching Hospital, Plzen, Czech Republic.
- 245 10
- $a Clostridium difficile infection in hospitalized patients at a Czech tertiary center: analysis of epidemiology, clinical features, and risk factors of fulminant course / $c K. Balihar, F. Kozak, J. Kozeluhova, V. Hejda, L. Fremundova, M. Krcma, L. Geigerova, T. Bergerova, M. Matejovic,
- 520 9_
- $a OBJECTIVE: Clostridium difficile infection (CDI) has been increasing in incidence, with significant morbidity and mortality, and is subject to geographical and institutional variability. We aimed to characterize epidemiology and clinical manifestations of CDI in a Czech tertiary care center and to identify risk factors of fulminant course. METHODS: All adult patients hospitalized with primary CDI in a 3-year period were retrospectively identified. Epidemiological and clinically descriptive data were extracted from medical records. Multivariate analysis was used to identify the risk factors of fulminant course. The relationship between incidence of CDI and antibiotic consumption was evaluated. RESULTS: Overall, 183 CDI patients, median age 67 years, were enrolled. Hospital-acquired CDI was present in 85% of cases. The incidence of CDI was 1/10,000 patient-days. Hospital-acquired CDI hospital mortality was 22.4%. Severe CDI (SCDI) was identified in 15.8% of patients, with 62% mortality. SCDI patients had longer onset of symptoms to diagnosis interval compared with mild CDI (P=0.05). Multivariate analysis showed that SCDI patients were older (P=0.018), and more frequently had abnormal abdominal physical findings (P=0.001), higher inflammatory markers (P<0.001), higher creatinine (P=0.002), and lower albumin (P<0.001) than patients with mild CDI. Analysis of antibiotic consumption at departments with the highest incidence of CDI showed a trend toward higher incidence of CDI associated with penicillin use (P=0.08) and a negative correlation of CDI incidence with nitroimidazoles consumption (P=0.03). CONCLUSION: CDI is less frequent in the conditions studied compared with literary data; however, the fulminant form has a very high mortality. Delayed recognition and treatment is a crucial determinant of the severity of CDI. The association between CDI and antibiotic consumption is less clear.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a antibakteriální látky $x terapeutické užití $7 D000900
- 650 _2
- $a infekce spojené se zdravotní péčí $x epidemiologie $x přenos $7 D003428
- 650 _2
- $a spotřeba léčiv $x statistika a číselné údaje $7 D004363
- 650 _2
- $a časná diagnóza $7 D042241
- 650 _2
- $a pseudomembranózní enterokolitida $x diagnóza $x farmakoterapie $x epidemiologie $x přenos $7 D004761
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a mortalita v nemocnicích $7 D017052
- 650 _2
- $a hospitalizace $7 D006760
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a incidence $7 D015994
- 650 _2
- $a délka pobytu $x statistika a číselné údaje $7 D007902
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a centra terciární péče $7 D062606
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kozak, Filip
- 700 1_
- $a Kozeluhova, Jana
- 700 1_
- $a Hejda, Vaclav
- 700 1_
- $a Fremundova, Lucie
- 700 1_
- $a Krcma, Michal
- 700 1_
- $a Geigerova, Lenka
- 700 1_
- $a Bergerova, Tamara
- 700 1_
- $a Matejovic, Martin
- 773 0_
- $w MED00001618 $t European journal of gastroenterology & hepatology $x 1473-5687 $g Roč. 26, č. 8 (2014), s. 880-7
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24942955 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150709 $b ABA008
- 991 __
- $a 20150730105428 $b ABA008
- 999 __
- $a ok $b bmc $g 1083662 $s 906317
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 26 $c 8 $d 880-7 $i 1473-5687 $m European journal of gastroenterology & hepatology $n Eur J Gastroenterol Hepatol $x MED00001618
- LZP __
- $a Pubmed-20150709